GlassScriptPhysician profile
John David Scott
NPI 1013962646
$242,372.25
in general payments reported to CMS, 2019-2025
27 companies · $110K in 2025
The $110K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $17K · 2021: $416 · 2022: $13K · 2023: $30K · 2024: $38K · 2025: $110K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $109K · Consulting Fee: $35K · Education: $14K · Travel and Lodging: $11K · Food and Beverage: $9,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109,200.00 |
| Consulting Fee | $34,807.50 |
| Education | $14,000.00 |
| Travel and Lodging | $11,421.36 |
| Food and Beverage | $9,008.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $119,395.12 | 2024-2025 | Zepbound |
| W. L. Gore & Associates, INC. | $85,476.29 | 2019-2025 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $16,926.71 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $12,830.54 | 2021-2025 | Echelon Endopath, Echelon Flex, Enseal X1 |
| Medtronic, INC. | $2,399.75 | 2022-2025 | Signia, Sonicision, Ligasure |
| Medical Device Business Services, INC. | $2,210.33 | 2024-2025 | Echelon Flex |
| Novo Nordisk INC | $974.90 | 2019-2025 | Wegovy |
| Teleflex LLC | $610.79 | 2021-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Apollo Endosurgery US INC | $245.65 | 2022 | |
| Covidien LP | $162.40 | 2020 | |
| Standard Bariatrics, INC. | $157.92 | 2022 | |
| Tela Bio, INC. | $154.10 | 2024 | Ovitex 2s |
| Enterra Medical, INC. | $126.00 | 2024 | |
| Stryker Corporation | $117.32 | 2022 | |
| Ethicon INC. | $115.13 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $93.84 | 2020 | |
| Lucid Diagnostics INC. | $80.50 | 2022 | |
| Nestle Healthcare Nutrition INC. | $62.99 | 2021-2023 | |
| Kvk-Tech, INC. | $42.69 | 2020 | |
| Baxter Healthcare | $29.84 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $29.10 | 2020 | |
| Endogastric Solutions, INC | $27.03 | 2022 | |
| Ascensia Diabetes Care US INC. | $24.50 | 2025 | |
| Intra-Sana Laboratories | $22.64 | 2021-2022 | |
| Abbvie INC. | $20.20 | 2019 | |
| Daiichi Sankyo INC. | $19.31 | 2021 | |
| Merck Sharp & Dohme LLC | $16.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.